1-3 of 3
calcium-activated potassium channel
Close
Save search
Sort by
Journal Articles

Mutations in the Gardos channel ( KCNN4 ) are associated with hereditary xerocytosis

Free
Brief Report
Edyta Glogowska, Kimberly Lezon-Geyda, Yelena Maksimova, Vincent P. Schulz, Patrick G. Gallagher
Journal: Blood
Blood (2015) 126 (11): 1281–1284.
https://doi.org/10.1182/blood-2015-07-657957
Published: 2015
Journal Articles

A Calcium-Dependent Pathway Determines Response to Lenalidomide in Del(5q) Myelodysplastic Syndromes

Free
Jing Fang, MD PhD, Xiaona Liu, BSc, Lyndsey Bolanos, BSc, Brenden Barker, BSc, Carmela Rigolino, BSc, Agostino Cortelezzi, MD, Esther Natalie Oliva, MD, Kyle J MacBeth, PhD, Kakajan Komurov, PhD, Daniel T Starczynowski, PhD
Journal: Blood
Blood (2014) 124 (21): 1898.
https://doi.org/10.1182/blood.V124.21.1898.1898
Published: 2014
Journal Articles

A 48-Week Open-Label Study of Senicapoc (ICA-17043), a Gardos Channel Blocker, in Patients with Sickle Cell Disease.

Free
Paul Swerdlow, MD, Kenneth Ataga, MD, Wally Smith, MD, Yogen Saunthararajah, MD, Jonathan W. Stocker, PhD
Journal: Blood
Blood (2006) 108 (11): 685.
https://doi.org/10.1182/blood.V108.11.685.685
Published: 2006